Menu

About Omni-stat Medical Inc

Omni-stat Medical Inc was recently established in 2018 to provide a solution to bleeding control in a hospital setting. We recognize the unique challenges healthcare professionals face when presented with bleeding wounds that vary broadly across the spectrum of medicine.

The unique proprietary technology behind OMNI-STAT & Celox hemostatic agents offers a fast and effective solution to achieve rapid hemostasis for minor, moderate, and severe bleeding, which may allow for shorter patient length of stay, and better management of staffing resources by reducing blood loss and the associated risks.

Omni-stat Medical Inc is leading the development of innovative solutions to manage bleeding control across Hospital Trauma, Emergency Medicine, Vascular Access, Wound Care & Surgical applications. We understand that product training is critical, which is why we offer a direct team of experts dedicated to providing information and product training to help achieve better patient outcomes. Our goal is to meet the needs of patients, and we are committed to offering the best healthcare solutions to healthcare professionals while providing efficacious products at low overall cost.

From battlefield to bedside, OMNI-STAT & CELOX have established a leading role in saving lives and have developed global recognition in trauma and hospital patient management. Together, we can help reduce blood loss and save lives, all within minutes.

When every second counts, OMNI-STAT & CELOX deliver.

_{CELOX Medical Limited, CELOX PPH Limited, Bio-Raze Limited and Omni-Stat Medical Inc are subsidiaries of Medtrade Products Limited.}

What is OMNI-STAT?

OMNI-STAT is an ideal and effective temporary topical external hemostatic agent. It is a fast, safe and effective method for controlling minor, moderate and severe bleeding ^{[ 8 ]}.

It is made of a proprietary composition which contains chitosan in the form of macroscopic high surface area granular flakes designed for maximum effectiveness in controlling bleeding.

It is available in a number of formulations. For more information click on See products.

See products

Chitosan technology

Our products are chitosan derived hemostats. The technology behind this is unique and proprietary.

chitosan derived hemostat

Chitin - a natural polysaccharide ^{[ 17 ]}, is a homo-polymer composed of the glucose derivative N-acetylglucosamine (GlcNAc). It is the structural element in the exoskeleton of crustaceans (i.e. crabs, shrimp) and the cell walls of fungi. Chitin sourced for OMNI-STAT is derived from shrimp and undergoes deproteinization as part of the early processing.

Partial deacetylation of chitin results in the production of chitosan, a polysaccharide comprising copolymers of the amino sugar glucosamine and N-acetylglucomsamine.

OmniStat Monograph

Further proprietary processing of chitosan leads to the optimisation and formation of a unique chitosan based hemostatic agent.

For further information, please click the link below and complete the form, to view or download a copy of OMNI-STAT Clinical and Scientific Monograph.

OMNI-STAT Clinical and Scientific Monograph

How our hemostats work?

The mechanism of action occurs through the absorption of fluid in the blood, the granules swell, gel and stick together to trap red blood cells creating a robust mechanical gel-like clot, that plugs the bleeding source and seals the wound ^{[ 2 ] & [ 8 ]}.

This mechanism works independently of classical coagulation pathways ^{[ 2 ]}.

OMNI-STAT is easily removed from the wounds after bleeding has stopped ^{[ 19 ] & [ 14 ]}. Any residual material can be irrigated away with water or saline.